M.S., Associate Director, Emerging BioPharma R&D Solutions, IQVIA
Mr. Caudle is Associate Director of Emerging BioPharma R&D Solutions at IQVIA, the Human Data Science Company™ that mobilizes unparalleled data, analytics, technology, and expertise through solutions connecting stakeholders to improve health. He has business experience across pharmaceuticals, biotech, and medical devices helping clients to proactively interpret regulations, understand processes and product technologies, make sound decisions, facilitate change, and drive business benefit. He assists Emerging BioPharma companies plan and implement highly targeted, data-driven clinical trials to advance an asset from first-in-man through global Phase III studies. Mr. Caudle currently serves as President-Elect on the Board of Directors for the Parenteral Drug Association in the Southeast U.S. and on several conference planning committees, including the 2018 PDA Cell & Gene Therapy and 2018 PDA Annual Meetings. He holds an MS in Food Science and a BS in Nutrition Science from Auburn University.
Presentation Title and Company Description
AI and Data Science Showcase: Next Generation Clinical Development for Emerging BioPharma
IMS Health & Quintiles are now IQVIA. From working together to define the plan for your asset, to trial implementation, through to launch and commercialization, IQVIA can help you find your path to success, while delivering results to investors, stakeholders, and regulatory authorities with confidence.